Literature DB >> 20797502

Coronary stents: current status.

Scot Garg1, Patrick W Serruys.   

Abstract

Coronary artery stents revolutionized the practice of interventional cardiology after they were first introduced in the mid-1980s. Since then, there have been significant developments in their design, the most notable of which has been the introduction of drug-eluting stents. This paper reviews the benefits, risks, and current status of Food and Drug Administration-approved drug-eluting stents. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Mesh：

Year:  2010        PMID： 20797502     DOI： 10.1016/j.jacc.2010.06.007

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


  77 in total

1.  Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration.

Authors:  Jia-Ning Wang; Ning Shi; Wei-Bing Xie; Xia Guo; Shi-You Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

2.  Comparison of vascular remodeling in patients treated with sirolimus-versus zotarolimus-eluting stent following acute myocardial infarction.

Authors:  Ki-Woon Kang; Young-Guk Ko; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Clin Cardiol       Date:  2011-12-12       Impact factor: 2.882

3.  Health economic evaluation of the use of drug-eluting stents : First results from the Drug-Eluting Stent Registry (DES.de).

Authors:  S N Willich; F Müller-Riemenschneider; D McBride; S Silber; K-H Kuck; C A Nienaber; S Schneider; J Senges; B Brüggenjürgen
Journal:  Herz       Date:  2012-02-02       Impact factor: 1.443

4.  Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention.

Authors:  Susheil Uthamaraj; Brandon J Tefft; Ota Hlinomaz; Gurpreet S Sandhu; Dan Dragomir-Daescu
Journal:  J Vis Exp       Date:  2015-09-18       Impact factor: 1.355

5.  Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation-Individual patient data pooled analysis from 6 randomized controlled trials.

Authors:  Maayan Konigstein; Mahesh V Madhavan; Ori Ben-Yehuda; Hussein M Rahim; Iva Srdanovic; Fotis Gkargkoulas; Ghazaleh Mehdipoor; Evan Shlofmitz; Akiko Maehara; Björn Redfors; Ankita K Gore; Thomas McAndrew; Gregg W Stone; Ziad A Ali
Journal:  Am Heart J       Date:  2019-04-12       Impact factor: 4.749

Review 6.  Coronary Stent Thrombosis- Predictors and Prevention.

Authors:  Helen Ullrich; Thomas Münzel; Tommaso Gori
Journal:  Dtsch Arztebl Int       Date:  2020-05-01       Impact factor: 5.594

7.  Parametric Optimization of 3D Printed Hydrogel-Based Cardiovascular Stent.

Authors:  Krishna Veerubhotla; Yugyung Lee; Chi H Lee
Journal:  Pharm Res       Date:  2021-05-10       Impact factor: 4.200

8.  Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention.

Authors:  Bhiken I Naik; Ellen C Keeley; Daryl R Gress; Zhiyi Zuo
Journal:  Anesthesiology       Date:  2014-09       Impact factor: 7.892

Review 9.  [Second-generation DES : New, but also cost-effective?].

Authors:  F Müller-Riemenschneider; T Reinhold; S N Willich
Journal:  Herz       Date:  2011-05       Impact factor: 1.443

10.  An IVUS transducer for microbubble therapies.

Authors:  Joseph P Kilroy; Abhay V Patil; Joshua J Rychak; John A Hossack
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2014-03       Impact factor: 2.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.